Core Viewpoint - Fujian Del Technology Co., Ltd. has terminated its IPO review, marking the second withdrawal in two months, with significant challenges in its financial performance and a strategic shift in its product offerings [1][2]. Financial Performance - Fujian Del's revenue from 2020 to 2024 was reported as 443.82 million, 1.26 billion, 1.70 billion, 1.42 billion, and 1.69 billion respectively, with a 16.52% decline in 2023 compared to the previous year [1]. - The net profit attributable to the parent company, excluding non-recurring gains and losses, showed a continuous decline from -10.33 million in 2020 to 86.18 million in 2023, with a significant drop of 79.72% in 2023 [1][2]. Product Dependency and Structural Changes - In 2022, lithium hexafluorophosphate, a key product, accounted for 39.73% of the company's main business revenue and 59.88% of its gross profit, indicating a high dependency on this segment [2]. - The company plans to reduce the revenue share of lithium hexafluorophosphate to 17.01% in 2023 and 12.28% in 2024, while increasing the share of fluorochemical basic materials from 34.02% in 2022 to 42.96% in 2024 [2]. Fundraising and Project Adjustments - The initial fundraising target was set at 3 billion, which was later reduced to 1.945 billion, with a significant cut in the number of projects from seven to three, focusing on semiconductor materials [3]. - The revised projects include the production line for electronic-grade chlorine trifluoride and other semiconductor-related initiatives, while dropping the new energy materials projects [3]. Financial Metrics - The company's operating income for 2024 is projected at 1.69 billion, with a net profit of 86.18 million, showing a recovery from 35.73 million in 2023 [4]. - The total assets increased from 5.36 billion in 2022 to 6.07 billion in 2023, reflecting growth despite the challenges faced [5].

Core Viewpoint - The company achieved record high revenue in H1 2025, but short-term profit pressure does not alter long-term growth potential, maintaining a "buy" rating [1] Revenue and Profit Summary - In H1 2025, the company reported revenue of 1.726 billion yuan, a year-on-year increase of 54.24% [1] - The net profit attributable to shareholders was 126 million yuan, a year-on-year decrease of 24.74% [1] - In Q2 2025, the company achieved revenue of 867 million yuan, a year-on-year increase of 29.22%, with net profit of 59 million yuan, down 44.63% year-on-year [1] Factors Affecting Revenue and Profit - Revenue growth was primarily driven by the gradual release of production capacity at Jinebo Fluorochemical, which sold 95,800 tons of anhydrous hydrofluoric acid, an increase of 46,800 tons compared to H1 2024 [1] - Domestic single mine production and costs remained stable compared to H1 2024, but profit decreased by nearly 20 million yuan due to technological upgrades at Xiangzhen Mining [1] - The Mongolian project’s beneficiation plant is still under construction, resulting in a net loss of 17.04 million yuan in H1 2025, including an exchange loss of 6.44 million yuan [1] - Jinshi New Materials and Jiangxi Jinling reported a combined net loss of 27.54 million yuan in H1 2025 due to the lithium industry's cycle not showing significant recovery [1] Profit Forecast Adjustments - Due to the current bottoming out of fluorite prices and the new projects not yet contributing profits, the company adjusted its profit forecasts for 2025-2027, expecting net profits of 298 million, 412 million, and 665 million yuan respectively [2] - The expected EPS for the same period is 0.35, 0.48, and 0.79 yuan, with corresponding PE ratios of 47.4, 35.0, and 21.2 times [2] - The company remains optimistic about the long-term stability of fluorite prices and the value reassessment from ongoing project advancements, maintaining a "buy" rating [2] Project Progress - The company’s projects are progressing as planned, with the single mine sales at 154,400 tons, a slight decrease of 4,500 tons year-on-year [2] - The Xiangzhen technological upgrade project is expected to be completed by the end of 2025 [3] - The Baotou "selection and processing integration" project produced 390,000 tons of fluorite powder and 103,000 tons of anhydrous hydrofluoric acid in H1 2025, contributing significant profits [3] - The Mongolian project is set to start trial operations by the end of October, processing approximately 200,000 tons of raw ore and producing 40%-45% grade fluorite blocks [3]

Core Viewpoint - The company reported significant growth in revenue and net profit for the first half of 2025, driven by rising prices of refrigerants and an improved supply-demand balance in the industry [1][2]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 2.828 billion yuan, a year-on-year increase of 38.58% [1] - The net profit attributable to shareholders reached 999.5 million yuan, up 159.22% year-on-year [1] - The net profit excluding non-recurring items was 986 million yuan, reflecting a growth of 163.61% [1] - In Q2 2025, revenue was 1.616 billion yuan, a 49.36% increase year-on-year, with net profit of 594 million yuan, up 158.98% [1] Refrigerant Pricing and Sales - The company's refrigerant sales volume was 62,000 tons in the first half of 2025, a decrease of 6.20% year-on-year, but the average selling price rose to 39,000 yuan per ton, an increase of 56.53% [2] - In Q2 2025, the average selling price of refrigerants reached 40,300 yuan per ton, up 55.06% year-on-year and 7.82% quarter-on-quarter [2] - The company's gross margin for refrigerants improved to 54.59%, contributing to an overall gross margin of 49.50% [2] Market Trends - As of August 23, 2025, the price of R22 has risen due to improved demand during the high-temperature season, with current quotes between 40,000 and 40,500 yuan per ton [3] - R32 is currently priced between 59,000 and 60,000 yuan per ton, with expectations for further increases [3] - R134a prices are stable at 50,000 to 51,000 yuan per ton, with upward price expectations [3] - R125 is primarily used for domestic purposes, while R227ea is experiencing supply shortages, with prices reaching 76,000 yuan per ton [3] Strategic Initiatives - The company is actively extending its industrial chain into high-value areas such as fluoropolymers and new energy materials [4] - Key projects include a lithium hexafluorophosphate project in Fujian and fluoropolymer projects in Zhejiang, which are progressing well [4] - The company is also advancing its fourth-generation refrigerants and preparing for future market expansions and technological iterations [4]

Core Viewpoint - Sanmei Co., Ltd. reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit, indicating robust growth and improved profitability metrics [1]. Financial Performance - Total revenue reached 2.828 billion yuan, a year-on-year increase of 38.58% [1] - Net profit attributable to shareholders was 999.5 million yuan, up 159.22% year-on-year [1] - In Q2 alone, revenue was 1.616 billion yuan, reflecting a 49.36% increase year-on-year, while net profit for the quarter was 594 million yuan, up 158.98% [1] - Gross margin improved to 49.5%, with a year-on-year increase of 83.96%, and net margin reached 34.96%, up 85.89% [1] Cost and Expenses - Total selling, administrative, and financial expenses amounted to 107 million yuan, accounting for 3.8% of revenue, which is a 142.49% increase year-on-year [1] - Operating cash flow per share increased significantly to 1.55 yuan, a 487.5% rise year-on-year [1] - Earnings per share rose to 1.63 yuan, marking a 158.73% increase year-on-year [1] Changes in Financial Items - Accounts receivable increased by 71.75% due to rising sales prices [2] - Prepayments surged by 157.61% due to increased advance payments for design fees, software fees, and goods [4] - Other receivables decreased by 22.03% as land guarantee deposits were recovered [5] - Long-term equity investments rose by 28.46% due to increased capital contributions and investment income [5] - Construction in progress increased by 45.19% due to significant investments in fluoropolymer projects [5] Liabilities and Cash Flow - Accounts payable increased by 50.42% due to higher payable engineering, equipment, and goods [7] - Contract liabilities surged by 43.99% due to increased advance payments for goods [9] - Tax liabilities rose by 168.3% as a result of increased operating income and corresponding taxes [9] - Net cash flow from operating activities increased by 487.5% due to higher cash receipts from sales [18] - Financing cash flow increased by 188.07% due to higher bank borrowings and employee stock plan contributions [19] Investment and Market Position - The company's return on invested capital (ROIC) was 11.11%, indicating average capital returns [20] - Analysts expect 2025 performance to reach 2.08 billion yuan, with an average earnings per share forecast of 3.41 yuan [22] - The largest fund holding in Sanmei Co., Ltd. is the E Fund Innovation Growth Mixed Fund, with a current scale of 2.268 billion yuan [23]

Core Viewpoint - The Shanghai Stock Exchange has decided to terminate the review of Fujian Del Technology Co., Ltd.'s application for an initial public offering (IPO) on the Shanghai main board, following the company's request to withdraw its application [1][2]. Company Overview - Fujian Del primarily engages in the research, production, and sales of fluorine-based new materials, including fluorochemical basic materials, new energy lithium battery materials, special gases, and semiconductor wet electronic chemicals [2]. - The company does not have a controlling shareholder, with the largest shareholder, Lai Zongming, holding 15.60% of the shares. No single shareholder can influence the board's decisions significantly [2]. Shareholding Structure - The actual controllers of Fujian Del are Lai Zongming, Hua Xiangbin, and Huang Tianliang, who collectively control 35.06% of the voting rights. They signed a "consensus action agreement" to ensure unified decision-making in shareholder meetings [3][4]. - To prevent deadlocks due to disagreements among the actual controllers, a supplementary agreement was signed on August 1, 2023, stipulating that no party can abstain from voting in case of disputes [4]. IPO Details - Fujian Del originally planned to issue between 115,420,403 and 183,314,756 shares, representing 10% to 15% of the post-issue total share capital. The offering was intended to be a public issuance of new shares without involving existing shareholders [4]. - The company aimed to raise 194.5 million yuan for projects including a production line for electronic-grade chlorine trifluoride, fluorine semiconductor materials, and a semiconductor-grade electronic materials project [4][5].

Core Viewpoint - Fujian Del Technology Co., Ltd. has withdrawn its IPO application, leading to the termination of its listing review by the Shanghai Stock Exchange [1] Company Overview - Fujian Del was established in 2014 and specializes in the research, production, and sales of fluorine-based new materials, including fluorochemical basic materials, new energy lithium battery materials, special gases, and semiconductor wet electronic chemicals. It is recognized as a national high-tech enterprise with core independent intellectual property rights [2] Financial Performance - The company ranked 422nd in the 2024 Hurun Global Unicorn List [3] - Revenue figures for the years 2022, 2023, and 2024 are 1.698 billion, 1.418 billion, and 1.687 billion CNY respectively, showing a decrease from 2022 to 2023 and a recovery in 2024 [3][4] - Net profit attributable to the parent company for the same years is 221 million, 119 million, and 130 million CNY, indicating a significant drop in 2023 [3][4] - The net profit after deducting non-recurring gains and losses for the years is 184 million, 36 million, and 86 million CNY, reflecting a similar trend [3][4] Key Financial Metrics - Total assets for 2024 are 6.856 billion CNY, up from 6.071 billion CNY in 2023 and 5.361 billion CNY in 2022 [4] - Equity attributable to shareholders of the parent company increased to 4.818 billion CNY in 2024 from 4.680 billion CNY in 2023 and 4.543 billion CNY in 2022 [4] - The company's gross profit margin for its main business is 16.04% in 2024, down from 16.79% in 2023 and significantly lower than 29.75% in 2022 [4] - The debt-to-asset ratio is 28.81% in 2024, compared to 21.95% in 2023 and 14.50% in 2022, indicating increasing leverage [4] Recent Developments - In the first quarter of 2025, the company achieved a revenue of 481 million CNY, a year-on-year increase of 46.03%, and a net profit after deducting non-recurring gains of 30 million CNY, up 43.10% year-on-year [4] - The company has proposed to raise funds for several projects, including a production line for electronic-grade trifluorochlorine and semiconductor materials, with a total planned investment of 19.45 billion CNY [7][8] Shareholder Structure - The company does not have a controlling shareholder, with the largest shareholder, Lai Zongming, holding 15.60% of the shares. Lai Zongming, Hua Xiangbin, and Huang Tianliang collectively control 35.06% of the voting rights and have signed a joint action agreement [8]

Core Insights - Sanmei Co., Ltd. reported a significant increase in revenue and profit for the first half of 2025, with a revenue of 2.828 billion yuan, representing a year-on-year growth of 38.58% and a net profit of 999.5 million yuan, up 159.22% [1][2] Financial Performance - The basic earnings per share for the reporting period was 1.63 yuan, with a weighted average return on equity of 14.40% [2] - The company's gross margin for the first half of 2025 was 49.50%, an increase of 22.59 percentage points year-on-year, while the net margin was 34.96%, up 16.15 percentage points from the previous year [2] - In Q2 2025, the gross margin reached 51.60%, a year-on-year increase of 21.03% and a quarter-on-quarter increase of 4.90%, with a net margin of 36.55%, up 15.34% year-on-year and 3.71 percentage points quarter-on-quarter [2] Expense Analysis - Total operating expenses for the first half of 2025 were 155 million yuan, an increase of 87.947 million yuan year-on-year, with an expense ratio of 5.50%, up 2.19 percentage points from the previous year [2] - Breakdown of expenses showed sales expenses increased by 23.71%, management expenses by 49.75%, R&D expenses by 35.28%, and financial expenses by 53.73% [2] Shareholder Information - As of the end of the first half of 2025, the total number of shareholders was 17,900, an increase of 3,519 or 24.52% from the previous quarter, while the average market value per shareholder decreased from 1.7186 million yuan to 1.6439 million yuan, a decline of 4.35% [2] Company Overview - Sanmei Co., Ltd. is located in Wuyi County, Zhejiang Province, and was established on May 11, 2001, with its listing date on April 2, 2019. The company specializes in the research, production, and sales of fluorinated chemical products, including fluorocarbon chemicals and inorganic fluorine products [3] - The main revenue sources are fluorinated refrigerants (80.91%), hydrofluoric acid (13.39%), fluorinated foaming agents (3.97%), and other products [3] - The company belongs to the basic chemical industry, specifically in the fluorochemical sector, and is associated with various concepts including PVDF, pension, pre-profit growth, mid-cap, and integrated circuits [3]

Group 1 - The chemical sector is experiencing a rally, with the Chemical ETF (516020) showing a price increase of 1.15% as of the latest report, following a brief period of fluctuation [1][2] - Key stocks in the sector, such as Hanjin Technology, Hongda Shares, and Juhua Shares, have seen significant gains, with Hanjin Technology hitting the daily limit up and others rising over 5% and 4% respectively [2][3] Group 2 - Zhongyuan Securities indicates that the chemical industry is undergoing a phase of improvement due to the reduction of excessive competition and capacity duplication, particularly in sub-sectors like pesticides, organic silicon, and polyester filament [3] - Debon Securities notes that the current cycle of capacity expansion in the chemical industry is nearing its end, with capital expenditure and fixed asset growth rates showing a downward trend since 2021 [3] - Donghai Securities highlights the structural optimization of supply, driven by domestic policies aimed at reducing competition, while also noting the challenges posed by rising raw material costs and geopolitical tensions affecting overseas supply [3] Group 3 - The Chemical ETF (516020) tracks the CSI sub-sector chemical industry index, with nearly 50% of its holdings concentrated in large-cap leading stocks, providing investors with opportunities to capitalize on strong performers in the sector [4] - Investors can also consider the Chemical ETF linked funds (Class A 012537/Class C 012538) for efficient exposure to the chemical sector [4]

Group 1 - The chemical sector is experiencing a strong upward trend, with the Chemical ETF (516020) showing a price increase of 1.15% as of the latest report [1] - The Chemical ETF has a significant portion of its holdings in large-cap stocks, including Wanhu Chemical and Salt Lake Shares, allowing investors to capitalize on strong market leaders [4] - Key stocks in the chemical sector, such as Hanjin Technology and Hongda Shares, have seen substantial gains, with Hanjin Technology hitting the daily limit and Hongda Shares rising over 5% [1][3] Group 2 - Zhongyuan Securities indicates that the chemical industry is moving towards a phase of recovery as the issue of overcapacity and excessive competition is expected to ease [3] - Debon Securities notes that the current cycle of chemical capacity expansion is nearing its end, with capital expenditure and fixed asset growth rates showing a downward trend [3] - Donghai Securities highlights that the domestic chemical industry is likely to see structural optimization, with significant cost advantages and technological advancements positioning Chinese companies to fill gaps in the global supply chain [3]

Group 1 - The chemical sector experienced a sudden surge, with stocks such as Hangjin Technology hitting the daily limit, and Hongda Co. and Juhua Co. seeing significant increases of over 6% and 4% respectively, while the chemical ETF (516020) rose by 1.15% [1] - The recent "anti-involution" trend has benefited the chemical sector, attracting substantial capital inflows, with the chemical ETF (516020) seeing a net subscription of nearly 140 million yuan over the last five trading days [1][3] - As of August 21, the social security fund held 129 stocks with a total market value of 33.2 billion yuan, with the chemical sector being the largest holding at 6 billion yuan [3] Group 2 - The chemical industry is expected to see a phase of improvement as the "anti-involution" measures are implemented, alleviating issues of overcapacity and excessive competition [3][4] - The chemical ETF (516020) is currently at a relatively low price-to-book ratio of 2.17, indicating a favorable long-term investment opportunity [3] - Analysts suggest that the "anti-involution" trend will be a key policy focus through 2025, leading to a more orderly competitive environment in the chemical sector and potential recovery in profitability [4] Group 3 - The chemical ETF (516020) tracks the CSI segmented chemical industry index, covering various sub-sectors, with nearly 50% of its holdings in large-cap leading stocks [4] - The ETF has shown strong performance, with significant net subscriptions indicating investor confidence in the sector's recovery [3][4] - The potential for increased dividend yields and improved cash flow in the chemical sector is highlighted, suggesting a shift from being a "cash-consuming" industry to a "cash-generating" one [4]